Mineralys Therapeutics, Inc. (MLYS) has a market capitalization of $1.81B and trades at $27.32. The 52-week range is 10.44-47.65.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11.9, Earnings Per Share (EPS) of $-2.29.
The stock has a beta of 0.69, operates in the Healthcare sector.
